Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.23 per Ordinary share on 8 April 2011 through the Company's ShareReward Plan ("the Plan"):
Mr A P Witty |
Acquisition of 41 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S M Bicknell |
Acquisition of 41 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr E J Gray |
Acquisition of 41 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S A Hussain |
Acquisition of 8 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Dr D Pulman |
Acquisition of 13 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr D S Redfern |
Acquisition of 41 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Ms C Thomas
Dr P J Vallance
Mrs V A Whyte |
Acquisition of 41 Ordinary shares under the Dividend Reinvestment element of the Plan
Acquisition of 17 Ordinary shares under the Dividend Reinvestment element of the Plan
Acquisition of 32 Ordinary shares under the Dividend Reinvestment element of the Plan
|
The Company and the above-mentioned persons were advised of this information on 11 April 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
11 April 2011